Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Prevention of Basal Cell Carcinoma in Basal Cell Nevus Syndrome
NCT00023621Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in basal cell carcinoma (BCC), sponsored by University of California, San Francisco. Started Feb 2001; status: completed.
02
Drugs
celecoxib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00023621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023621.